Novo Nordisk

Pharma

In Europe, Lilly exec says MFN will affect Foundayo launch

Eli Lilly will focus on the telehealth market when it launches its oral obesity treatment Foundayo in Europe, International Chief Patrik Jonsson said.

Kevin Dunleavy Jun 24, 2026 11:20am

Pharma money pharma money pharma profits Big Pharma sales drug sales

Obesity meds, China drive $2T in projected 2032 drug sales: report

Jun 23, 2026 9:00am

Man holding remote control in dark room with TV and red and blue lights

Eli Lilly, Novo Nordisk top AI citation share

Jun 22, 2026 8:07am

Wegovy pill oral wegovy obesity semaglutide

'Familiarity' with oral Wegovy has triggered its quick uptake

Jun 18, 2026 11:15am

Novo's security breach claimed by dual hacking groups: reports

Jun 17, 2026 11:45am

Novo Nordisk opens Czech plant to produce next-gen obesity drugs

Jun 17, 2026 11:22am